NCBI PubMed Centralopen access
From anti-drug antibody incidence to clinical relevance: interpreting highly sensitive immunogenicity assays in biosimilars.
distributed systems architecture
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 645442
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.